Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.700 $1.03 Friday, 10th May 2024 HOOK stock ended at $0.768. This is 4.00% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.46% from a day low at $0.740 to a day high of $0.81.
90 days $0.605 $1.03
52 weeks $0.410 $2.05

Historical Hookipa Pharma Inc. prices

Date Open High Low Close Volume
Feb 29, 2024 $0.81 $0.85 $0.741 $0.768 649 429
Feb 28, 2024 $0.700 $0.85 $0.688 $0.80 1 760 428
Feb 27, 2024 $0.655 $0.699 $0.640 $0.684 705 750
Feb 26, 2024 $0.638 $0.677 $0.638 $0.666 934 657
Feb 23, 2024 $0.640 $0.656 $0.611 $0.640 733 642
Feb 22, 2024 $0.643 $0.670 $0.632 $0.656 417 604
Feb 21, 2024 $0.643 $0.695 $0.631 $0.658 448 135
Feb 20, 2024 $0.662 $0.670 $0.640 $0.665 690 102
Feb 16, 2024 $0.663 $0.670 $0.640 $0.661 379 424
Feb 15, 2024 $0.665 $0.685 $0.655 $0.660 658 936
Feb 14, 2024 $0.631 $0.697 $0.631 $0.665 438 586
Feb 13, 2024 $0.680 $0.680 $0.605 $0.639 686 222
Feb 12, 2024 $0.680 $0.690 $0.663 $0.666 542 211
Feb 09, 2024 $0.670 $0.677 $0.651 $0.677 416 801
Feb 08, 2024 $0.680 $0.680 $0.660 $0.667 232 599
Feb 07, 2024 $0.695 $0.695 $0.660 $0.674 279 748
Feb 06, 2024 $0.660 $0.694 $0.640 $0.670 296 116
Feb 05, 2024 $0.683 $0.683 $0.630 $0.635 461 661
Feb 02, 2024 $0.645 $0.685 $0.630 $0.680 548 344
Feb 01, 2024 $0.621 $0.647 $0.621 $0.640 237 079
Jan 31, 2024 $0.612 $0.644 $0.600 $0.621 316 472
Jan 30, 2024 $0.606 $0.640 $0.606 $0.612 489 911
Jan 29, 2024 $0.642 $0.647 $0.579 $0.630 2 398 460
Jan 26, 2024 $0.708 $0.730 $0.682 $0.701 320 754
Jan 25, 2024 $0.718 $0.720 $0.692 $0.710 227 472
Click to get the best stock tips daily for free!

About Hookipa Pharma Inc.

Hookipa Pharma. HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-2... HOOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT